Publication | Open Access
CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban
15
Citations
24
References
2016
Year
Higher CHA<sub>2</sub>DS<sub>2</sub>-VASc scores are associated with increased incidence of major bleeding in nonvalvular atrial fibrillation patients receiving rivaroxaban.
| Year | Citations | |
|---|---|---|
Page 1
Page 1